-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Abvc Biopharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Abvc Biopharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$187K, a 94.4% increase year-over-year.
- Abvc Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$10.5M, a 36% increase from 2022.
- Abvc Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$16.4M, a 27.9% decline from 2021.
- Abvc Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$12.8M, a 21.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)